BRIEFING ON DRUGS FROM INDIA SOUGHT

Washington, Feb. 14: A bipartisan group of powerful US lawmakers on Wednesday sought a congressional briefing on contaminated drugs from India and China used in the treatment of high blood pressure.

Since July last year, at least 15 recalls have been issued for a class of drugs known as angiotensin II receptor blockers (ARB), which are generally used to treat high blood pressure.

The recalls appear to be connected to at least two foreign drug manufacturing facilities – Zhejiang Huahai Pharmaceutical in China and Hetero Labs in India.